Study shows molecular mechanism of SARS-CoV-2 Mpro

NewsGuard 100/100 Score

The Computational Biochemistry Group's research has been selected as one of the most outstanding studies of 2020 by the journal Chemical Science.

The Computational Biochemistry Research Group at Universitat Jaume I (UJI) has managed to reveal the molecular mechanism of SARS-CoV-2 Mpro, one of the essential enzymes for the replication process of the virus responsible for the COVID-19 pandemic.

The results of this research, which may be useful for the development of new antiviral drugs, have been obtained by Katarzyna Świderek and Vicent Moliner and have just been published in Chemical Science. In addition, this study has been selected by this journal as one of the most relevant of 2020.

The work, carried out in the Department of Physical and Analytical Chemistry of the School of Technology and Experimental Sciences (ESTCE), has focused on the study of the functioning of the SARS-CoV-2 Mpro enzyme by means of computational methods that combine quantum mechanics with molecular mechanics (QM/MM)

Journal reference:

Swiderek, K & Moliner, V., et al. (2020) Revealing the molecular mechanisms of proteolysis of SARS-CoV-2 Mpro by QM/MM computational methods. Chemical Science.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses